 Elizabeth Woodruff
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 13 | 2025 | 586 | 1.620 |
Why?
| | Period Circadian Proteins | 4 | 2018 | 33 | 1.290 |
Why?
| | Circadian Rhythm | 7 | 2018 | 514 | 1.280 |
Why?
| | Corticosterone | 6 | 2018 | 244 | 1.160 |
Why?
| | Prefrontal Cortex | 4 | 2018 | 328 | 0.960 |
Why?
| | Extinction, Psychological | 2 | 2018 | 92 | 0.930 |
Why?
| | Glucocorticoids | 4 | 2017 | 535 | 0.840 |
Why?
| | Fear | 2 | 2018 | 366 | 0.790 |
Why?
| | ARNTL Transcription Factors | 3 | 2017 | 17 | 0.730 |
Why?
| | Suprachiasmatic Nucleus | 4 | 2017 | 19 | 0.730 |
Why?
| | Claudin-4 | 4 | 2025 | 17 | 0.700 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 5 | 2025 | 132 | 0.640 |
Why?
| | Genomic Instability | 3 | 2025 | 66 | 0.630 |
Why?
| | Cystadenocarcinoma, Serous | 4 | 2025 | 84 | 0.630 |
Why?
| | Pituitary-Adrenal System | 3 | 2017 | 165 | 0.620 |
Why?
| | Circadian Clocks | 2 | 2017 | 59 | 0.620 |
Why?
| | Hypothalamo-Hypophyseal System | 3 | 2017 | 198 | 0.610 |
Why?
| | Receptors, Steroid | 1 | 2017 | 45 | 0.530 |
Why?
| | Polycomb Repressive Complex 1 | 3 | 2026 | 66 | 0.470 |
Why?
| | Adrenalectomy | 6 | 2018 | 71 | 0.470 |
Why?
| | Adrenal Glands | 2 | 2017 | 77 | 0.470 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 592 | 0.440 |
Why?
| | Stress, Psychological | 3 | 2017 | 1153 | 0.430 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2024 | 141 | 0.370 |
Why?
| | beta Catenin | 2 | 2025 | 253 | 0.340 |
Why?
| | Wnt Signaling Pathway | 3 | 2025 | 210 | 0.330 |
Why?
| | Rats, Sprague-Dawley | 6 | 2018 | 2540 | 0.310 |
Why?
| | Cell Line, Tumor | 10 | 2026 | 3550 | 0.300 |
Why?
| | Endometrial Neoplasms | 2 | 2021 | 208 | 0.280 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 735 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2017 | 196 | 0.250 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 883 | 0.240 |
Why?
| | Aurora Kinase A | 1 | 2026 | 62 | 0.240 |
Why?
| | Azepines | 1 | 2026 | 107 | 0.230 |
Why?
| | Animals | 17 | 2026 | 38109 | 0.230 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2025 | 1462 | 0.230 |
Why?
| | Tumor Escape | 1 | 2025 | 49 | 0.230 |
Why?
| | Immune Evasion | 1 | 2025 | 64 | 0.220 |
Why?
| | Phthalazines | 1 | 2025 | 64 | 0.220 |
Why?
| | Tryptophan Oxygenase | 1 | 2024 | 33 | 0.210 |
Why?
| | Fallopian Tubes | 1 | 2024 | 33 | 0.200 |
Why?
| | Paraventricular Hypothalamic Nucleus | 3 | 2017 | 33 | 0.190 |
Why?
| | Piperazines | 1 | 2025 | 381 | 0.190 |
Why?
| | Pyrimidines | 1 | 2026 | 533 | 0.180 |
Why?
| | Autophagy | 1 | 2024 | 286 | 0.180 |
Why?
| | RNA, Messenger | 3 | 2018 | 2832 | 0.170 |
Why?
| | In Situ Hybridization | 3 | 2017 | 319 | 0.170 |
Why?
| | Wnt Proteins | 1 | 2021 | 133 | 0.160 |
Why?
| | Protein Kinase Inhibitors | 1 | 2026 | 970 | 0.150 |
Why?
| | Rats | 5 | 2018 | 5614 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 1786 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 917 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2018 | 133 | 0.140 |
Why?
| | Photoperiod | 2 | 2015 | 55 | 0.140 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2026 | 930 | 0.140 |
Why?
| | Septal Nuclei | 1 | 2017 | 23 | 0.130 |
Why?
| | Mice | 8 | 2026 | 18365 | 0.130 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 405 | 0.130 |
Why?
| | Immediate-Early Proteins | 1 | 2017 | 48 | 0.130 |
Why?
| | Sexual Behavior, Animal | 1 | 2017 | 57 | 0.130 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2020 | 269 | 0.130 |
Why?
| | Mental Recall | 1 | 2018 | 222 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 635 | 0.120 |
Why?
| | Female | 18 | 2026 | 78376 | 0.120 |
Why?
| | Stress, Physiological | 2 | 2017 | 453 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2016 | 83 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2025 | 1958 | 0.120 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 147 | 0.110 |
Why?
| | Brain | 3 | 2017 | 2941 | 0.110 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2015 | 27 | 0.110 |
Why?
| | Oligodendroglia | 1 | 2017 | 187 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2032 | 0.110 |
Why?
| | Auditory Perception | 1 | 2015 | 114 | 0.100 |
Why?
| | Acoustic Stimulation | 1 | 2015 | 334 | 0.100 |
Why?
| | Humans | 17 | 2026 | 144957 | 0.090 |
Why?
| | Cues | 1 | 2015 | 326 | 0.090 |
Why?
| | Male | 8 | 2018 | 72406 | 0.080 |
Why?
| | Mutation | 1 | 2021 | 4099 | 0.080 |
Why?
| | Cell Survival | 2 | 2025 | 1098 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2609 | 0.070 |
Why?
| | Cell Proliferation | 2 | 2026 | 2499 | 0.070 |
Why?
| | Time Factors | 1 | 2018 | 7183 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2884 | 0.070 |
Why?
| | Restraint, Physical | 2 | 2017 | 75 | 0.060 |
Why?
| | Macrophages | 2 | 2024 | 1511 | 0.060 |
Why?
| | Molecular Docking Simulation | 1 | 2026 | 124 | 0.060 |
Why?
| | Disease Progression | 2 | 2025 | 2852 | 0.060 |
Why?
| | Drug Synergism | 1 | 2025 | 357 | 0.050 |
Why?
| | Micronuclei, Chromosome-Defective | 1 | 2024 | 8 | 0.050 |
Why?
| | Amino Acid Transport System ASC | 1 | 2024 | 12 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 102 | 0.050 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2024 | 47 | 0.050 |
Why?
| | BRCA2 Protein | 1 | 2024 | 67 | 0.050 |
Why?
| | Anoikis | 1 | 2023 | 30 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 36 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 114 | 0.050 |
Why?
| | Tryptophan | 1 | 2024 | 181 | 0.050 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 13 | 0.050 |
Why?
| | Cell Cycle | 1 | 2025 | 597 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 241 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2025 | 619 | 0.040 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 44 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 80 | 0.040 |
Why?
| | Lysine | 1 | 2023 | 302 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 826 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 629 | 0.040 |
Why?
| | Sex Factors | 2 | 2017 | 2114 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 531 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 254 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 780 | 0.040 |
Why?
| | DNA Repair | 1 | 2022 | 256 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 348 | 0.040 |
Why?
| | DNA Damage | 1 | 2022 | 430 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 434 | 0.030 |
Why?
| | Recurrence | 1 | 2021 | 1135 | 0.030 |
Why?
| | Genes, fos | 1 | 2017 | 37 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 695 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 998 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2017 | 268 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 647 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2017 | 72 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 605 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 269 | 0.030 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2016 | 72 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1141 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1742 | 0.030 |
Why?
| | Hypothalamus | 1 | 2015 | 153 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2017 | 465 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 4293 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4569 | 0.020 |
Why?
| | Motor Activity | 1 | 2017 | 722 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1311 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1490 | 0.020 |
Why?
| | Biomarkers | 1 | 2024 | 4275 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 984 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 2197 | 0.020 |
Why?
| | Neurons | 1 | 2017 | 1642 | 0.020 |
Why?
|
|
Woodruff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|